3-Part Deep Tech Pharmaceutical Report

There are more than 10,000 diseases afflicting humans today, but only five percent of these diseases have approved treatment options. Although spend on pharmaceutical research and development is increasing, 96% of potential drugs never make it to market.

We explore:

1. How to reduce the cost of biologics with innovation intelligence
2. The future of adeno-associated virus therapies
3. A deep dive into RNA therapeutics

Each report can be read as a standalone analysis or combined for a more holistic, 360-degree industry overview.